Federal Register / Vol. 75, No. 169 / Wednesday, September 1, 2010 / Notices 53719 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in Schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a) (2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

of the Code of Federal Regulations 

§ 1301.34(a), this is notice that on May 

5, 2010, AllTech Associates Inc., 2051 

Waukegan Road, Deerfield, Illinois 

60015, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as an importer of 

the basic classes of controlled 

substances listed in schedule I and II: 

Drug Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Heroin (9200) ............................... I 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Hydrocodone (9193) ..................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

The company plans to import these 

controlled substances for the 

manufacture of reference standards. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than October 1, 2010. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substance in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a), 21 U.S.C. 823(a), and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: August 3, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–21747 Filed 8–31–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

This is notice that on May 25, 2010, 

Noramco, Inc., 1440 Olympic Drive, 

Athens, Georgia 30601, made 

application by letter to the Drug 

Enforcement Administration (DEA) for 

registration as an importer of Poppy 

Straw Concentrate (9670), a basic class 

of controlled substance listed in 

schedule II. 

The company plans to import the 

listed controlled substance in bulk to 

manufacture other controlled substances 

solely in bulk for distribution to the 

company’s customers. 

As explained in the Correction to 

Notice of Application pertaining to 

Rhodes Technologies, 72 FR 3417 

(2007), comments and requests for 

hearings on applications to import 

narcotic raw material are not 

appropriate. 

As noted in a previous notice 

published in the Federal Register on 

September 23, 1975, (40 FR 43745), all 

applicants for registration to import a 

basic class of any controlled substances 

in schedule I or II are, and will continue 

to be, required to demonstrate to the 

Deputy Assistant Administrator, Office 

of Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: August 13, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–21750 Filed 8–31–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on May 17, 2010, 

Cambridge Isotope Lab, 50 Frontage 

Road, Andover, Massachusetts 01810, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of Morphine (9300), a 

basic class of controlled substance listed 

in schedule II. 

The company plans to utilize small 

quantities of the listed controlled 

substance in the preparation of 

analytical standards. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such a substance, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than November 1, 2010. 

Dated: August 3, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–21739 Filed 8–31–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to § 1301.33(a) of Title 21 of 

the Code of Federal Regulations (CFR), 

this is notice that on April 29, 2010, 

Cambrex Charles City, Inc., 1205 11th 

Street, Charles City, Iowa 50616, made 

application by letter to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

Gamma Hydroxybutyric Acid (GHB) 

(2010), a basic class of controlled 

substance listed in schedule I. 

The company plans to manufacture 

Gamma Hydroxybutyric Acid (GHB) 

(2010) in bulk active pharmaceutical 

ingredient (API) form for distribution to 

the company’s customers. 

Any other such applicant, and any 

person who is presently registered with 


hsrobinson on DSK69SOYB1PROD with NOTICES